Ò»¡¢ÕÐƸ»ù±¾Ìõ¼þ£º
1¡¢ÒÑÈëѧµÄ2022¼¶Ë¶Ê¿Ñо¿Éú2-3Ãû»òÕß²©Ê¿Ñо¿Éú1-2Ãû£¬±¾¿Æ/˶ʿ±³¾°¿ÉΪÉúÎïѧ£¬Ò©Àíѧ£¬Óлú»¯Ñ§£¬Ò©Îﻯѧ»òÏà¹ØÁìÓò¡£
2. ¶ÔÒ©Îï·¢ÏÖ£¬Ïà¹ØÉúÎïѧ»úÖÆÑо¿£¬Ò©Àíѧ»òת»¯Ò½Ñ§¹¤×÷ÓÐÇ¿ÁÒµÄÐËȤ
3. ¹¤×÷×÷·ç»ý¼«¿Ï¸É£¬ÓÐÁ¼ºÃµÄÓëÈËÏà´¦ºÍ¹µÍ¨µÄÄÜÁ¦¼°ÍŶӺÏ×÷¾«Éñ¡£
¶þ¡¢¹¤×÷ÄÚÈÝ
Ö÷Òª¿ªÕ¹¿¹Ö×Áö£¬¿¹²¡¶¾£¬¿¹·ÎËðÉË£¬¿¹ÒÖÓôµÈÑо¿·½ÏòÏà¹ØµÄÒ©ÎïºÏ³É£¬»îÐÔÆÀ¼Û£¬»úÖÆ̽¾¿µÈ¿ÆÑпÎÌ⹤×÷¡£ÐèÕ÷Çóµ¼Ê¦Í¬Òâºó£¬À´ÎÒËùÁªºÏÅàÑø£¬ÐèÍê³É2ÄêµÄ¿ÎÌâÑо¿¹¤×÷£¬¿ÉÔÚÎÒËùÍê³ÉÂÛÎļ°SCIÎÄÕÂ׫д¡£
Èý¡¢Ñо¿Éú´ýÓö£º
ÁªºÏÅàÑøÆڼ䣬²¢Ìṩ¾ßÓÐÓÅÁ¼µÄÑо¿Éú²¹Öú£¬Ë¶Ê¿£¨2500£©£¬²©Ê¿£¨4000-5000£©£¬ÌṩѧÉúסËÞ¡£¿ÆÑй¤×÷Æڼ䣬½«Óдø½ÌÀÏʦÌṩÍ걸µÄ¿ÎÌâ¹æ»®¼°ÊµÑ鹤×÷Ö¸µ¼¡£Íê³É¹¤×÷½ÏºÃÕߣ¬ÎÒÃǽ«ÍƼöºóÆÚ²©Ê¿ÉêÇ뿼ºË¼°¹¤×÷ÍƼö¡£
µØÖ·£º±±¾©Êк£µíÇø̫ƽ·27ºÅÔº
ÁªÏµÈË£º13699139985£¨Î¢ÐÅͬºÅ£© ÀîÀÏʦ£ºbnuhuaxuelpy@163.com
ÓÐÐËȤµÄͬѧÇë·¢¼òÀúÖÁÓÊÏ䣬´ËÕÐƸ³¤ÆÚÓÐЧ
ËÄ¡¢ÊµÑéÊÒ½üÄêÀ´Ñо¿³É¹û
1. Chongyi Ai1, Zhuang Wang1, Pengyun Li, Mengyuan Wang, Wenjuan Zhang, Huijuan Song, Xu Cai, Kai Lv*, Xingjuan Chen*, Zhibing Zheng*,
Discovery and pharmacological characterization of a novel benzimidazole TRPV4 antagonist with cyanocyclobutyl moiety, European Journal of Medicinal Chemistry, 249, 2023,115137£¨Q1, IF: 7.088)
2. Pengyun Li1, Changkai Jia1, Zhiya Fan, Xiaotong Hu, Wenjuan Zhang, Ke Liu, Shiyang Sun, Haoxin Guo, Ning Yang, Maoxiang Zhu, Xiaomei Zhuang*, Junhai Xiao*, Zhibing Zheng*, Song Li. Discovery of Novel Exceptionally Potent, Highly Selective, and Orally Active c-MET PROTACs for the Treatment of Tumors with MET Alterations. Acta Pharmaceutica Sinica B (2023, Q1, IF:14.90)
3. Pengyun Li, Qiaohong Lin, Shiyang Sun, Ning Yang, Yu Xia, Shengjie Cao, Wenjuan Zhang, Qian Li, Haoxin Guo, Maoxiang Zhu, Yilong Wang*, Zhibing Zheng*, Song Li. Cell Death Disease, 13, 808 (2022). (Q1, IF: 9.69).
4. Wenjuan Zhang1, Pengyun Li1, Shiyang Sun, Changkai Jia, Ning Yang, Xiaomei Zhuang**, Zhibing Zheng*, Song Li. Discovery of highly potent and selective CRBN-recruiting EGFRL858R/T790M degraders in vivo. European Journal of Medicinal Chemistry 238 (2022) 114509 (Q1, IF: 7.088)
5. Tingting Yang1, Wenjuan Zhang1, Shengjie Cao, Shiyang Sun, Xu Cai, Lei Xu, Pengyun Li**, Zhibing Zheng *, Song Li., Discovery of highly potent and selective EGFR TKIs against NSCLC based on molecular dynamic simulation. European Journal of Medicinal Chemistry. 2022 ,15;228 (Q1, IF: 7.088)
6. Pengyun Li, Shengjie Cao, Yubin Huang, Yanan Zhang, Jie Liu, Xu Cai, Lulu Zhou, Jianbin Li, Zefei Jiang, Lihua Ding*, Zhibing Zheng*, Song Li*, Qinong Ye*. A novel chemical inhibitor suppresses breast cancer cell growth and metastasis through inhibiting HPIP oncoprotein. Cell Death Discovery. 2021 Jul 29;7(1) (Q2, IF£º7.109)
7. 4-¼×»ù-1H-¶þ·¼»ùÀàÑÜÉúÎïÔÚÖƱ¸¿¹Ö×ÁöÒ©ÎïÖеÄÓÃ;¡£Ö£Ö¾±ø£¬ÀîÅôÔË£¬ÀîËÉ£¬ÖÓÎ䣬Ф¾üº££¬ÖÜÐÁ²¨£¬ÀîÐÐÖÛ£¬·®Ê¿Ó£¬Ð»·Æ£¬Ð¤µä¡£¹«¿ªºÅ£ºCN202010748566.8.
8. Ò»ÖÖ°±»ùà×à¤ÑÜÉúÎï¼°Æä×÷ΪEGFRÀÒ°±ËἤøÒÖÖƼÁµÄÓ¦Óá£Ö£Ö¾±ø£¬ÀîÅôÔË£¬ÀîËÉ£¬ÀîÐÐÖÛ£¬Ð¤¾üº££¬ÖÜÐÁ²¨£¬ÖÓÎ䣬²ÜÊ¥½à£¬·®Ê¿Ó£¬Ð¤µä¡£¹«¿ªºÅ£ºCN202111083628.
9. c-METµ°°×°ÐÏò½µ½â¼Á¼°ÆäÒ½Ò©ÓÃ;¡£Ö£Ö¾±ø£¬ÀîÅôÔË¡¢ÀîËÉ¡¢¼Ö³¤¿¡¢Ð¤¾üº£¡¢ÖÓÎä¡¢ÀîÐÐÖÛ¡¢ÖÜÐÁ²¨¡¢·®Ê¿Ó¡¢Ð¤µä¡£ÉêÇëºÅ£º202210995745.0
10. È¡´úÝÁ¼×õ£°·ÀàÑÜÉúÎï¼°ÆäÒ½Ò©ÓÃ;¡£ÉêÇëºÅ£º202210996213.9
Î塢ʵÑéÊÒÌõ¼þ
ĿǰʵÑéÊÒÖ÷Òª¿ªÕ¹¿¹Ö×Áö£¬¿¹²¡¶¾£¬¿¹ÒÖÓô£¬¿¹·ÎËðÉËÏà¹ØÒ©ÎïºÍ»úÖƵķ¢ÏÖ£¬¿ÎÌâ½øչ˳Àû¡£ÊµÑéÊÒÓµÓгä×ãµÄ¿ÎÌâ¾·Ñ£¬³Ðµ£¶àÏî¹ú¼Ò¡¢¾ü¶Ó¿ÎÌ⣬É豸ÆëÈ«£¬¸ø¿ÆÑÐÈËÔ±ÌṩӵÓÐÁ¼ºÃµÄ¿ÆÑй¤×÷»·¾³£¬ºóÆÚÈôÒª¼ÌÐøÉîÔ콫ÌṩÍƼö¡£ÊµÑéÊÒÏÖÓÐÒ©Îﻯѧ£¬Ò©Àíѧ£¬·Ö×ÓÉúÎïѧÏà¹ØµÄ¿ÆÑб³¾°£¬ÈÃÄãÔÚ½»²æѧ¿ÆÖÐÓиü¿ìµÄ½ø²½¡£ÊµÑéÊÒ¼ò½é£º±¾ÊµÑéÊÒÊô¡°¿¹¶¾Ò©ÎïÓ붾Àíѧ¹ú¼ÒÖصãʵÑéÊÒ¡±Óë¡°Ó¦¼±·À¿ØÒ©Î﹤³Ì¼¼ÊõÑо¿ÖÐÐÄ¡±Á½¸ö¹ú¼Ò¼¶Ñо¿»ú¹¹ÖØÒª×é³É²¿·Ö£¬¾ß±¸´Ó¼ÆËã»úµ½Éú²úÏßµÄÐÂÒ©Ñз¢ÄÜÁ¦£¬¿ÉÒÔʵÏÖ»ù´¡Ñо¿ÓëÊг¡µÄÎÞ·ì½Ó¹ì£¬ÎªÉúÎïÒ½Ò©¿Æ¼¼È˲ŵijɳ¤Óë·¢Õ¹ÌṩÁ˹ãÀ«Æ½Ì¨¡£
£¨ÕÐƸ³¤ÆÚÉúЧ£¬»¶Ó¹ã´óѧÉúÉêÇ뱨Ãû!!!£© |